Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry.
Alberto Cordero-FortM Rosa Fernández Del OlmoGustavo A Cortez QuirogaCesar Romero-MenorLorenzo FácilaJosé Seijas-AmigoAisa FornoviJuan R MurilloMoisés Rodríguez-MañeroMaría C Bello MoraAlfonso ValleSandin MiriamRoman F PamiasJordi BañerasPedro B GarcíaMaria M Clemente LorenzoSergio Sánchez-AlvarezLuis López-RodríguezJosé R González-JuanateyPublished in: Journal of cardiovascular pharmacology (2022)
This multicentre and retrospective registry of real-world patients treated with PCSK9 inhibitors highlights significant gender differences in LDLc reduction.